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ABSTRACT
PROSTATE VOLUME DELINEATION AND SEED LOCALIZATION USING A 3-T 
MAGNETIC RESONANCE SPECTROMETER
by
Jason Eric Davis
Dr. Phillip W. Patton, Examination Committee Chair 
Associate Professor of Health Physics 
University of Nevada, Las Vegas
With approximately one in six men affected by prostate cancer at some point in their 
lives, effective treatment o f the disease remains a focus o f oncology research. Effective 
treatment using radiation requires the delivery of a significant dose to the prostate volume 
while sparing surrounding sensitive structures. Treatment success can then be 
determined by localization of the seeds following implantation and the calculation of a 
dose distribution across the target volume. Magnetic Resonance Imaging (MRI) yields 
images with soft tissue contrast that is superior to CT or ultrasound, but has been under- 
appreciated as a dosimetric tool due to the difficulty in localizing the implanted seeds.
To optimize scan parameters for seed localization, a phantom was constructed of 
tissue-equivalent gelatin. Seeds were implanted during construction so various scan 
protocols could be tested for seed visualization and volume calculation prior to patient 
studies. Five healthy volunteers and five patients with permanently implanted seeds 
were then imaged to validate the phantom studies. Images were evaluated based on 
anatomical clarity and seed visualization rates.
Ill
Optimization o f the scan protocols for use with this equipment yields images with 
clearly defined anatomical boundaries as well as clearly defined seeds. Phantom volume 
measurements deviated from known values by less than 2.5% T2-weighted images 
provide superior anatomical delineation, but suffer from broad susceptibility artifacts that 
make determination of seed locations difficult. Proton density-weighted images clearly 
show seed locations and tissue margins. The selection of a 1 mm slice thickness and a 4 
mm interslice gap allowed maximum seed visualization rates o f 93.3%
Keywords: prostate, brachytherapy, dosimetry, magnetic resonance imaging
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CHAPTER 1 
INTRODUCTION
With an estimated 234,460 new cases projected to be diagnosed yearly, prostate 
cancer is the second most common cancer among men (ACS 2006). In fact, based on 
incidence rates from 2001-2003, it is estimated that one in six men will be diagnosed with 
the disease at some point in their lives (NCI 2006), and that 27,350 lives will be lost to 
prostate cancer in the year 2006 alone (ACS 2006).
Although early stages o f the disease are either asymptomatic, or display symptoms 
that resemble those o f others common conditions, such as lower back pain, urine flow 
obstructions, or burning during urination, routine screening through the prostate specific 
antigen (PSA) blood test has allowed more than 90% of the cancers to be diagnosed in 
the earlier local and regional stages. With appropriate treatment, patients diagnosed in 
these stages have a 5-year survival rate of nearly 100% (ACS 2006). The challenge to 
any kind of cancer treatment using radiation is delivering a therapeutic dose to the 
targeted volume while sparing surrounding healthy tissues.
Prostate Anatomy and Surrounding Structures
About the size o f a walnut in younger men, the prostate is a small, somewhat 
triangular gland situated low in the male pelvis. As shown in Fig. 1, it is framed
anteriorly by the pubic symphysis, posteriorly by a layer o f fat that separates the prostate 
from the rectum, inferiorly by the urogenital diaphragm, and superiorly by the bladder 
(Pollack 2003).
Pubic Symphysis
Prostatic
Urethra
Seminal VesiclesBladder
Prostate
Rectum
Urogenital Diaphragm
Figure 1. Prostate location within the pelvis. (UUHSC 2006)
Although classically thought o f as a histologically homogeneous organ, the four 
regions o f the prostate are actually different in regards to tissue composition and 
pathologic susceptibility (McNeal 1981). However, since nearly 99% of the prostate is 
composed o f glandular tissue, it is hardly surprising that more than 95% o f malignant 
neoplasms in the prostate are adenocarcinomas, or tumor cells arising from glandular
epithelial eells (Pollack 2003). Adenocarcinomas tend to be slow-growing and have 
historically been believed to require the achievement of a tumor volume o f over 4 cm^ 
before metastasizing (Crawford et al. 2001). It is this tendency toward slow growth that 
makes adenocarcinoma an ideal candidate for treatment with radiation therapy, since the 
tumor can generally be detected through routine screening methods well in advance of 
extracapsular migration.
While the prostate itself is generally considered to be fairly radioresistant, this 
observed resistance to radiation does not necessarily extend to the surrounding tissues 
and structure. The proximity o f the rectal wall to the anterior edge o f the rectum makes 
avoidance o f incidental irradiation of the rectal mucosa extremely difficult in most forms 
o f radiation treatment. With a tolerance dose o f 70 Gy, accidental irradiation o f the rectal 
wall may cause atrophy o f the mucosa, serosal breakdown, stenosis, and fibrosis leading 
to prolonged obstructive effects (Hall 2000). Despite this biological limitation, there is 
no generally accepted limit on rectal dose during prostate treatment (Potters 2003). The 
American Association o f Physicists in Medicine (AAPM) Task Group No. 64 does 
however recommend limiting the rectal dose to less than 90 Gy to reduce incidence o f 
rectal bleeding and ulceration (Yu et al. 1999).
Because o f their locations, the urethra and urinary bladder are also of great 
consideration during radiotherapy o f the prostate. Although the bladder is in intimate 
contact with the base o f the prostate, the urethra’s location within the prostatic volume 
makes it an organ of primary concern in the planning o f any treatment o f the prostate. 
The fact that the urethra does not follow a straight-line path through the prostate volume
may further complicate efforts to spare this organ without precise image guidance 
(McNeal 1981).
The urinary bladder is composed o f basal cells with a relatively high renewal rate 
making any radiation induced cell damage possible with relatively low doses. Although 
occurring in a minority of cases, instances o f fibrosis, urinary stricture, hematuria, and 
focal ulceration have been reported in patients receiving a dose o f between 65 and 70 Gy 
(Milosevic and Gospodarowicz 2003). Differences in implant technique, the use of 
combination therapies, methods of urethral delineation, and other factors have 
complicated the ability o f researchers to set dose limits to minimize the risk o f urinary 
stricture or fibrosis o f the urethra. However, studies performed before the introduction of 
peripheral loading techniques have suggested that a dose in excess o f 400 Gy can be 
associated with an increased risk of urethral morbidity (Crook et al. 2005). Additionally, 
the incidence o f urinary morbidity may be further enhanced in patients with a recent 
history o f transurethral resection of the prostate (TURP) to treat benign prostatic 
hyperplasia (Potters 2003).
Permanent Brachytherapy
Due to the lack o f a surface dose and the sparing o f surrounding tissues, permanent 
interstitial brachytherapy allows for the delivery of a higher localized dose than external 
beam therapies. The highly conformai nature o f the treatment allows the physician and 
treatment staff to ereate a treatment plan that is eapable o f minimizing the dose to 
sensitive structures like the prostatic urethra. This treatment may also appeal to patients 
that seek non-surgical treatment on an outpatient basis which will result in a minimal
disturbance o f the patients’ lifestyle (Potters 2003). Since the process is minimally 
invasive, recovery is rapid relative to radical prostatectomy, allowing patients to return to 
work and normal activities within a few days (Ragde et al. 2000).
Brachytherapy is generally reserved for patients with early stage prostate cancer, 
when the tumor is still relatively slow growing and still confined within the prostatic 
capsule (Pollack 2003). For this treatment, small seed pellets are placed directly into the 
prostate, approximately one centimeter apart, through small needles. Currently, the 
seeds, numbering from 40 to more than 100, are inserted through the perineum in order to 
help ensure a more uniform seed placement, as well as avoid complications that may 
arise from pubic arch obstruction o f the needle placement (Potters 2003).
The seeds may be placed by one of two methods. The first involves the use o f a pre­
scan trans-rectal ultrasound (TRUS) to delineate the prostate volume. Images from these 
scans are used to formulate a treatment plan that includes pre-determined needle 
locations, and a planning target volume with a 2-3 mm margin, which is manually 
delineated by a physician (Potters 2003). The seeds are then placed through pre-loaded 
needles. The principal disadvantage o f this technique is that it relies on the prostate being 
in the exact same position during treatment as during the pre-planning scans (Pollack 
2003). There is also a risk o f prostate volume changes if  the preplanning scans are carried 
out more than 2-3 weeks before treatment. This risk is especially evident in patients 
undergoing hormonal therapy for volume reduction (Yu et al. 1999).
The intraoperative planning method is an alternative to preoperative treatment 
planning. In this method, seed placement is monitored throughout the procedure either 
through fluoroscopy, CT, MRI, or TRUS. Seeds are placed individually through the
Mick applicator system, which gives the treatment staff more control over the seed 
spacing. As the procedure progresses, the seed locations are noted on the planning 
computer and a profile o f the seed placement in three dimensional space is developed. 
This method is not without its drawbacks, however. The treatment time is increased due 
to the individual placement o f the seeds which, in turn, increases the total cost of 
performing the treatment (Pollack 2003). Additionally, this method does not account for 
the possibility that the seeds may migrate following implantation, thus altering the dose 
distribution.
Rationale for Post-Implant Dosimetry
The ability to accurately assess the dosimetry of the implant is considered the most 
important factor in understanding the relationship between implant quality and treatment 
efficacy (Prete et al. 1998). A study performed by Stock et al. (1998) suggested that the 
dose delivered to the target volume is the most significant predictor o f biochemical 
failure following '^^I implants. In fact, it was shown that patients that received a D90, the 
dose covering 90% of the target volume, greater than or equal to 140 Gy had a 4-year rate 
of freedom from biochemical failure o f 92%. By comparison, those patients that received 
a D 9 0  of less than 140 Gy had a biochemical failure freedom rate o f only 6 8 %.
Since dose is inversely proportional to the square of the distance from the source, it is 
not surprising that the dose distribution is largely dependant on the implant geometry. 
Due to gland deformation, needle deviation, and gland swelling, however, the actual 
geometry o f the implant is not the same as the planned geometry. Accurate post-implant 
dosimetric analysis allows for the identification o f areas o f the gland that may have
received a suboptimal dose. These regions may then be treated either through a second 
brachytherapy procedure or though external beam radiation (Ravindran et al. 2006).
Further, information obtained during the imaging component o f a post-implant 
dosimetric study can be used to evaluate or even predict post-treatment complications. 
Visualization o f an implanted seed that has localized in or overly close to the urethra, 
penile bulb, or neurovascular bundle may be useful for the urologist if a patient presents 
with hematuria, urinary obstruction, or erectile dysfunetion (Coakley et al. 2001).
Additionally, as is the case with many medical procedures, the quality o f a prostate 
implant depends on the skill and experience o f the procedure staff (Yu et al. 1999). It has 
been demonstrated that there is a learning curve associated with performing permanent 
implantation brachytherapy (Lee et al. 2000), which has led Yu and colleagues to 
recommend that institutions continuously monitor implant quality to allow for technique 
improvements and to avoid perpetuation o f errors that may compromise implant quality. 
Based on these factors, post-implant dosimetry is considered mandatory by both the 
AAPM and the American Brachytherapy Society (Yu et al. 1999; Nag et al. 2000). 
Dosimetric Methods
Methods for calculating the dose from a permanently implanted brachytherapy source 
are detailed by the AAPM Radiation Therapy Committee Task Group No. 64 (Yu et al. 
1999). Commonly, the isotropic point source approximation is used for dose calculation. 
From this model, the total dose delivered at a distance r by an '^^I or ’°^Pd seed is given
by
D = Doxl.443x7;/2 (1)
In this equation, T 1/2 is the half-life o f the implanted isotope and the initial dose rate is 
given by
2% , (2)
r
where Sk is the air kerma strength with units o f cGy cm^ h"\ A is the dose rate constant, 
g(r) is the radial dose function, and ^  is a dose anisotropy constant. The radial dose 
function accounts for scatter and absorption in the tissue and is only defined along the 
transverse axis o f the source. Also accounting for absorption, scatter, and other dose 
distribution effects around the source, the dose anisotropy constant is an approximation 
of the dose anisotropy function that can be used only when the point source 
approximation given above is used. This factor also takes into account self-absorption 
within the source and the absorption o f photons within the encapsulating material. Both 
the radial dose function and the dose anisotropy constant are tabulated for the most 
common brachytherapy materials in the recommendations by AAPM Radiation Therapy 
Task Group No. 43 (Nath et al. 1995). From these simplified equations, it is evident that 
accurate dosimetric evaluation requires precise determination o f the prostate volume, as 
well as the seed location within that volume.
Imaging Studies
Historically, prostate implants have been imaged using plane film radiography. 
W hile this allow s for excellent visualization o f  the implanted seeds, as seen in Fig. 2, the 
soft tissue o f the prostate itself does not image well using traditional radiography. 
Additionally, despite the fact that the implanted seeds image well on film, localization
Figure 2. Radiograph showing prostate seeds within the pelvis. Note the lack of 
prostate anatomical information (Cleveland Clinic 2006).
is complicated by the fact that their arrangement leads to image overlapping of almost 
25% of the seeds (Su et al. 2004).
With its wide availability, low expense, and potential for intra-operative use, 
ultrasound is considered an attractive option for prostate imaging both before and after 
implantation (Han et al. 2003). There are technical issues that limit ultrasound’s 
usefulness in determining prostate volume, however. Typically, prostate volumes from 
ultrasound are calculated using the ellipsoid formula
V = lx  w x h x  — , (3)
6
where V is the total prostate volume, / is the length or transverse diameter measured at the 
point o f maximal diameter, and w  is the width or diameter measured in the 
anteroposterior plane. Finally, h is the longitudinal diameter o f the gland, measured
along the midsagittal plane between the genitourinary diaphragm and the bladder neck. 
This method has been shown to underestimate the prostate volume by as much as 30% 
(Matthews et al. 1996). The ellipsoid formula method o f volume calculation is 
intrinsically imprecise due to the fact that the prostate is not perfectly elliptical in shape. 
Additionally, variations in the choice of the three planes of measurement may exist 
between sonographers or even between scans for the same sonographers because 
transducer orientation relative to the prostate volume is operator dependent (Rahmouni et 
al. 1992).
A prostate volume interobserver variability ranging from 20% to 50% is a testament 
to the difficulty o f accurately delineating the prostate volume on TRUS images (Smith et 
al. 2003). This variability is most notable near the base and apex, and along the anterior 
edge. As illustrated in Fig. 3, this variability may be further complicated by the fact that 
implanted seeds will degrade the image along the prostate borders (Smith et al. 2003).
Pre-implant Post-implant
Figure. 3. Pre- and post-implant TRUS images demonstrating the prostatic margin 
obscuring effects o f the implanted seeds (Smith et al. 2003).
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The determination o f seed location using ultrasound is also limited by technical issues. 
Most notably, as seen in Fig. 4, the seeds appear as small bright spots on a background 
that is already cluttered by bright speckles, making them difficult to isolate. 
Additionally, the implanted sources are difficult to distinguish from calcifications and 
other structures that are echogenic. Finally, the brightness o f the seeds on the ultrasound 
image is dependant on the orientation o f the seeds relative to the transducer (Wei et al. 
2006). This orientation is also operator dependant and may vary between scans 
(Rahmouni et al. 1992). These factors combine to limit the ability o f even experienced 
staff to delineate and localize the seeds. A study performed using four brachytherapists 
showed that the locations and identities o f only 2 0 % of the seeds were agreed on by all 
four o f the therapists (Han et al. 2003).
Pre-implant Post-implant
Figure 4. Pre- and post-implant TRUS images showing bright spots (arrows) that 
may be interpreted as implanted sources (Han et al. 2003).
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Although better at imaging the implanted seeds than ultrasound, CT also has 
limitations that prevent its use as a single imaging modality for pre- and post-procedural 
studies. Because CT uses x-rays to create images similar to traditional radiography, 
contrast between different tissue types is dependant on the density of the tissues. 
Unfortunately, the prostate and surrounding tissues are very similar in density, which 
makes discrimination between the tissues difficult. For instance, definition o f the 
prostatic urethra is extremely difficult without the use o f a Foley catheter. The inability 
to distinguish the prostate from the anterior wall of the rectum, the levitator ani muscles, 
and the neurovascular bundles contributes to the subjective nature of volume 
determination using CT. The unintentional inclusion o f portions of these tissues within 
the contoured prostate volume may also lead to an overestimation of the prostate volume, 
which will impact the calculated dose in both pre- and post-implant studies (Yu et al. 
1999).
Currently most implants are carried out with an ultrasound scan for pre-plaiming to 
preserve anatomic detail and a CT for post-implant studies to maximize the ability to 
determine seed positions. This multi-modality imaging method has limitations as well. 
TRUS is typically performed in the supine lithotomy position in order to more easily 
access the rectum and to mimic the position the patient will be in during the implantation 
procedure. Because o f limitations in the bore o f most CT equipment however, the post­
implant CT is generally performed in the standard supine position (Narayana 1997). Due 
to this difference o f  positioning and because o f  normal prostate motion between the 
scans, errors may be produced in the registration of the two images, which may lead to 
inaccuracies in seed registration (Wei et al. 2006).
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In order to compare the prostate and seed locations in the two different image types, 
clinicians must align the images using implanted fiducial markers or anatomic landmarks. 
Many clinicians align the two images based on the observed locations of either the 
rectum or the urethra. This technique may not lead to a perfect registration because of 
the fact that the urethra does not image well on CT without catheter administered contrast 
(Narayana et al. 1997b). Additionally, the ultrasound is performed using a transrectal 
probe which may cause a rectal and prostate deformation which is not seen on the CT 
images. These registration errors may be further complicated by the difference in volume 
estimations produced using ultrasound and CT. Studies have shown that prostate CT 
images, even when performed pre-implant, are an average o f 47% larger than the 
estimated ultrasound volumes (Narayana et al. 1997a). In order to minimize these errors, 
many researchers are focusing on ways to use the same imaging modality for both pre- 
and post-implantation imaging studies.
MR Physics
Magnetic resonance imaging takes advantage o f intrinsic properties o f atomic nuclei 
and their behavior in the presence o f a strong magnetic field. Protons, neutrons, and 
electrons each have an intrinsic property called spin. Since subatomic particles and 
nuclei carry a charge or charge distribution, and because magnetic fields are generated by 
the movement of a charge through space, the rotation of these particles about a central 
axis induces a magnetic moment. This moment causes individual nuclei to behave like a 
magnet with a north and south pole.
13
Similar to rotating celestial bodies or a spinning top, subatomic particles also exhibit 
a second-order motion known as precession, which is the result o f an interaction between 
an external force and the spinning object. For magnetic resonance, this is the interaction 
o f the externally applied magnetic field with the spinning particles. Precession is the 
rotation o f the magnetic moment about the axis o f the rotating body. The frequency co of 
this precession depends on the strength o f the magnetic field and gyromagnetic ratio of 
the rotating body, and is shown by the Larmor equation
a> = yB (4)
In this equation, B  is the external magnetic field and y is the gyromagnetic ratio o f the 
processing body. The gyromagnetic ratio is unique to each element and is the ratio o f the 
element’s magnetic moment to its angular momentum (Bushberg et al. 2002).
Because the magnetic moment is a vector quantity, it can be thought o f as being 
composed o f different components o f the transverse and longitudinal planes. The 
component o f the magnetic moments parallel to the external magnetic field is known as 
the longitudinal vector M%. Perpendicular to the external magnetic field is the transverse 
component M%y. While the magnitude o f the magnetic moment vector is the same for like 
particles, the orientation o f these magnetic moments in the absence o f an external 
magnetic field is random, producing a net magnetization o f zero. When placed in a 
strong magnetic field, the magnetic moments o f the nuclei are observed to align with the 
direction o f the magnetic field (Bushberg et al. 2002).
A  m icroscopic view  o f  the proeess reveals that it is actually the precessional axis that 
aligns with the magnetic field. Since the transverse spin orientations are still random in 
this configuration, there is no net magnetization perpendicular to the externally applied
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field (Bo) and the observed net magnetization is parallel to Bo. The nuelei align either 
parallel or anti-parallel to the external field. The majority of the nuclei align themselves 
in the lower energy state, or parallel to the field. In actuality, the population difference 
between these two states is approximately three in one million nuclei. Given the large 
quantity of hydrogen nuclei in a given sample volume, however, this difference is 
generally sufficient to produce a detectable change in the magnetic field (Brown and 
Semelka 2003).
Production o f an MR signal is actually an application o f Faraday’s law of 
electromagnetic induction. When a proton precesses so that its magnetic field intersects 
the plane o f a coil o f wire, a current is induced in the coil. This current can then be 
detected as an MR signal (Hendee and Ritenour 2002). In order to generate this signal, a 
radiofrequency (RF) pulse at the Larmor frequency is applied to the sample, rotating the 
longitudinal component o f the magnetic moment into the transverse plain. Additionally, 
this applied RF pulse induces a phase coherence in the Mxy component o f the magnetic 
moment so that the individual protons precess in phase with one another. The 
combination o f the phase coherence o f Mxy and the rotation of M% into the transverse 
plane maximizes the magnitude o f the magnetization in the transverse plane. Since this 
plane is perpendicular to the coil, this translates to a maximum signal intensity.
Inhomogeneities in the material cause the protons to begin to precess at different 
frequencies. As the protons begin to de-phase, the vector components o f the transverse 
magnetization begin to cancel each other, resulting in a loss o f  signal intensity. This 
process is time dependent and is known as free induction decay (FID). The FID decays 
as phase coherence is lost between the individual spins caused by differences in the local
15
magnetic field. This exponential relaxation decay is called the T2 relaxation time and is 
determined by the molecular structure o f the material. This characteristic allows for 
improved contrast over CT between layers o f materials that may have different molecular 
compositions but similar densities.
Returning the excited protons back to the equilibrium magnetization is a long process 
relative to the loss of signal due to the de-phasing of transverse magnetization. Each 
individual excited spin must release its energy to the lattice. This exponential regrowth is 
called spin-lattice relaxation and relies on the characteristics o f the spin interaction with 
the lattice. The time necessary to recover 63% of the equilibrium magnetization 
following a 90 degree radiofrequency pulse is known as the T1 relaxation time (Bushberg 
et al. 2 0 0 2 ).
MRI Prostate Studies
It has been demonstrated that over or underestimating the prostate volume can have 
an impact on the dose distribution throughout the prostate volume (Reynier et al. 2004). 
Given the small dimensions o f the prostate, it is evident that even small changes in 
prostate border delineation can have a large impact on the calculated volume and dose 
distributions. For example, overestimating the border o f a 3 cm x 5 cm x 4 cm elliptical 
prostate by as little as 3 mm increases the calculated volume by 25% (Prete et al. 1998). 
In order to minimize dose distribution errors, the ideal imaging modality for treatment 
planning and post-implant dosimetry should be able to determine the prostate volum e as 
accurately as possible. Studies comparing MRI contoured prostate volume calculations 
to measured prostate volumes following prostatectomy have shown that MRI estimates
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are as close as 92% o f measured values with the discrepancy being attributed to the 
periprostatic tissues contained in the excised specimen volume that would not be 
accounted for in imaging studies (Rahmouni et al. 1992).
To improve the signal-to-noise ratio and, subsequently, the spatial resolution of 
prostate MR images, many clinics use an endorectal coil. These coils may be 
contraindicated in some patients, however, including those with a recent history o f pelvic 
radiotherapy or surgery. Additionally, the endorectal coil suffers from motion artifacts 
caused by rectal peristalsis. Furthermore, as described by Sosna and colleagues (2004) 
pressure from the insertion o f the coil causes a deformation of the posterior border o f the 
prostate. This deformation is demonstrated by the warping o f a spectroscopy grid when 
used as an overlay to an anatomic image as shown in Fig. 5.
Figure 5. Prostate deformation due to insertion of an endorectal probe. The picture 
on the left shows a probe-in image o f the prostate with associated spectroscopy grid. 
The image on the right is probe-out and shows how the spectroscopy grid must be 
warped to contain the same tissue volume. (Alterovitz et al. 2006).
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Such deformation has been shown to cause seed displacement as much as 9.377 mm from 
the position without the endorectal probe (Alterovitz et al. 2006). Perhaps more notably, 
the images are also somewhat inhomogeneous because of the near field effect that causes 
a region o f signal hyperintensity near the rectum with a rapid fall off o f signal near the 
anterior border o f the gland. This region o f signal fall off can lead to unsatisfactory 
visualization of the prostatic apex and neurovascular bundles (Torricelli et al. 2006). 
Each o f these artifacts can be seen in Fig. 6.
Figure 6. Representative axial T2-weighted image using an endorectal coil at 1.5T. 
This image reveals some o f the shortcomings o f using the endorectal coil, including 
artifacts tfom bowel peristalsis seen in the left-right direction shown by the gray 
arrow, near-field brightening that affects the peripheral zone shown by the white 
arrow, and some distortion o f the posterior border o f the gland shown by the black 
arrows (Sosna et al. 2004).
Recent work by Sosna et al. (2004) and Torricelli et al. (2006) demonstrates that 
image quality obtained at 3.0 Tesla (T) with an external phased array coil is comparable 
to those obtained at 1.5 T with an endorectal coil without the associated gland 
deformation or peristaltic motion artifacts. Despite the fact that some o f the criteria used
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to define image quality are subjective, it has been determined that the external 3T 
technique has clinical relevance for those patients that are contraindicated for endorectal 
coil usage or who refuse the use o f an endorectal coil for personal or psychological 
reasons (Torricelli et al. 2006).
Source Localization
MR has not seen widespread acceptance as a post-implant imaging tool because of 
the difficulty in localizing the implanted seeds. Although used to investigate 
extraprostatic seed distribution following permanent seed implant brachytherapy, MR has 
not been widely utilized for dosimetric analysis due to the difficulty in distinguishing 
individual seeds from one another and from other structures with low signal (Coakley et 
al. 2001). Shown in Fig. 7, the seeds show up on the image as a signal void, which may 
resemble the appearance o f blood vessels or air bubbles.
Figure 7. Transverse T2-weighted fast SE MR image o f 3-mm-thick section of 
prostate treated with brachytherapy. Multiple radiation therapy seeds are in the 
position o f the neurovascular bundle (arrows) bilaterally (Coakley et al. 2001).
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However, sequences can be optimized to either accentuate the lack of signal from the 
sources, allowing a skilled reader to distinguish blood vessel signal voids from those 
produced by other sources. In this case, proper identification is the result o f noting that 
the signal void surrounding a blood vessel is also surrounded by an area o f increased 
signal intensity adjacent to the signal void due to the chemical shift between the blood 
and surrounding tissues (Dubois et al. 1997).
Pulse sequences must be chosen carefully, however. As demonstrated by 
McLaughlin et al. (2002), the signal distortion produced by the presence o f the seeds may 
obscure the margins o f T1-weighted images to the point where there is no volume 
determination benefit over CT. Careful selection o f sequence parameters may minimize 
the susceptibility artifact around the implants, allowing for a more accurate representation 
o f the seed location within the glandular space.
The aim o f this work is to explore the usefulness o f magnetic resonance imaging as a 
single imaging modality for pre- and post-implant imaging studies. Specifically, the goal 
is to determine whether images acquired from a variety o f pulse sequences using a 
cardiac coil coupled with 3T MRI will be adequate for pre-implant treatment planning 
and post-implant dosimetric analysis o f permanently implanted brachytherapy seeds. 
Adequacy will be determined by the degree to which anatomic detail allows for precise 
delineation o f prostate boundaries, as well as the ability to accurately localize the 
implanted seeds.
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CHAPTER 2 
PHANTOM STUDIES
Introduction
An anthropomorphic phantom allows for the development and repeated testing of 
imaging protocols without the need to inconvenience patients. Additionally, creation of 
the phantom in the lab allows for the prostate volume and seed locations to be measured 
during construction, creating a baseline of measurements for comparison to later 
measured results. In order for a phantom to be useful for MR imaging, it must be stable 
at room temperature and should closely mimic the density and magnetic properties of the 
tissues that are being represented.
From the wide range o f values available in the literature, the target T2 relaxation time 
for the simulated prostate volume was chosen to be 80 ms and the target T2 relaxation 
time for the surrounding tissues was chosen to be 150 ms. A target T1 relaxation time of 
937 ms was selected for the prostate volume and a relaxation time o f 207 ms was used for 
the surrounding tissues. These values were chosen to correlate with the central gland and 
peripheral zone, respectively, of the prostate as determined by Gibbs et al. (2001).
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Materials and methods 
Phantom construction
In order to approximate the T1 and T2 relaxation times of the prostate and 
surrounding tissues, a phantom composed of mixtures of animal hide gelatin and agar gel 
was constructed. It has been shown by Blechinger et al. (1988) that adjusting the 
concentrations o f agar gel and animal hide gelatin in a phantom allows a researcher to 
control T2 relaxation times. In general, increasing the concentration o f animal hide 
gelatin with respect to the total phantom volume increases the T2 relaxation time 
(Blechinger et al. 1988). Work performed by D ’Souza et al. (2001) has also shown that 
the addition of a copper chloride salt (C uC f • 2 H2O), with ethylenediaminetetraacedic 
acid (EDTA) used as a chelating agent, lowers the T1 relaxation time values.
Using the ratios presented by Blechinger (1988), it was determined that a ratio of 
30% animal hide gelatin to 70% agar gel should be used for the prostate volume, and a 
ratio of 80% animal hide gelatin to 20% agar gel should be used for the surrounding 
tissues. For comparison of images obtained with varying numbers of seeds, three 
separate 50 ml phantoms were constructed to represent the prostate.
To make each prostate volume, 50 ml o f distilled water was heated to boiling. A 
mixture of 3.48 g o f dry animal hide powder and 1.58 g o f dry agar powder was slowly 
added to the water while continuously stirring. The dry powders were sifted very slowly 
into the water to avoid clumping. Similarly, the mixture was stirred slowly to avoid the 
introduction o f air bubbles into the gel. After the dry powder mixture had been 
dissolved, air bubbles were skimmed off the top of the mixture and discarded.
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Enough distilled hot water was added to 0.0515 g o f EDTA to dissolve the chelating 
agent in a separate beaker. To this volume, 0.03 g C uC f was added, stirred in, and 
allowed to dissolve completely before adding to the gel mixture. Finally, 0.15 ml of 
formaldehyde was stirred into the mixture directly before pouring the molten mixture into 
the 50 ml mold. The mold capsule was then partially submerged in an ice water bath to 
allow the phantom material to cool and solidify. During this step, the capsule was 
occasionally agitated gently by hand to avoid gravitational sedimentation. This entire 
process was repeated to create a total of three prostate phantoms.
Initially, it was decided that placement o f the seeds between successive layers of 
gelatin in the prostate phantom would yield relatively consistent seed placement with no 
air voids resulting from piercing the gel to place the seeds. The imitation seeds were 
produced by trimming a 0.8 mm diameter titanium wire to 5 mm lengths. Each seed was 
placed by hand on top o f a 2 mm thick layer of cooled gelatin. Another layer of gelatin 
was then poured on top o f the seeds and allowed to cool. As shown in Fig. 8, placing
Figure 8. Prostate phantom showing seed orientation perpendicular to the central axis 
o f the phantom.
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the seeds by this method results in a seed orientation that is perpendicular to the central 
axis o f the com pleted phantom. This orientation is more consistent with the older 
retropubic method o f seed placement. Since the purpose of this study is the creation of a 
tissue mimicking phantom to evaluate current brachytherapy methods, an orientation 
perpendicular to the axis o f the phantom is not optimal for this study. Therefore, it was 
determined that the seeds must be placed parallel to the central axis o f the phantom.
To closely mimic current implant procedures, a template was constructed that would 
allow the seeds to be placed uniformly into the gelatin material. The template had holes 
that were pre-drilled with a 1 cm space between each hole to ensure uniform spacing of 
the implanted dummy seeds (Fig. 9).
Figure 9. Seed placement template shown from the top (a) to show the spacing o f the 
holes and from the side (b) to show the placement o f the prostate phantom beneath 
the template.
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For each implanted seed, an 18 gauge needle was inserted into the gelatin material 
through the pre-drilled template hole. A seed was dropped through the needle, and a 
separate length of wire threaded through the needle was used to stabilize the implanted 
seed while the needle was withdrawn. Seeds were placed with a lateral spacing ranging 
incrementally from 2 mm to 10 mm, with the majority of the seeds spaced between 4 mm 
and 6 mm apart. To fill any air voids left by the needle, a small amount of molten 
phantom material was poured onto the top o f the phantom.
Due to material losses during transfer o f the gelatin between vessels, as well as the 
addition o f material to fill voids left by seed placement, it was necessary to confirm the 
volume o f the prostate phantom before placement within the surrounding material. To 
this end, the volume o f one phantom was measured by immersion. A 200 ml beaker was 
filled approximately to the 100 ml line with DI water and the fluid level marked. The 
phantom was then completely immersed in the beaker and the resulting fluid level was 
marked. Water was then removed from the beaker by pipet and transferred to a 100 ml 
graduated cylinder until the fluid level in the beaker matched the level marked before 
immersion of the phantom. The volume of displaced fluid was recorded and would serve 
as the basis for comparison with volume measurements made from the MRI images.
The surrounding tissue phantom was created in much the same manner as the prostate 
volume phantom. To avoid having to cut through the surrounding material phantom to 
insert the prostate phantom, the larger phantom was made in four separate stages with 
cooling in between so that the prostate phantoms eould be plaeed on top of a solid layer. 
A complete list o f materials used for the phantom sections can be seen in Table 1.
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Table 1. Composition of tissue mimicking prostate and surrounding tissues.
Tissue Material Used
Quantity 
Per Layer
Total
Quantity
Surrounding Tissue DI Water 1890 ml 7560 ml
Agar Powder 17.01 g 68.04 g
Animal Hide Powder 350.60 g 1402.04 g
EDTA 1.95 g 7 J 9 g
Copper Chloride 1.15g 6.05 g
Formaldehyde 15.12 ml 60.48 ml
Prostate DI Water 50 ml 150 ml
Agar Powder 158 g 4.74 g
Animal Hide Powder 1.04 g
EDTA 0.05 g 0.15 g
Copper Chloride 0.03 g 0.09 g
Formaldehyde 0.15 ml 0.45 ml
With the large quantities used, slow mixing and stirring becomes even more 
important in order to avoid the excessive production o f air bubbles and material losses 
through clumping. After mixing the first stage, the gelatin was poured into a two gallon 
plastic bucket and allowed to cool in an ice water bath before placing the first prostate 
volume phantom  on top o f the solidified gelatin. It was noted that briefly touching 
the flat edge o f the prostate phantom to boiling water before placing on the solidified 
surrounding material layer allows the two phantoms to bond without the formation o f air 
pockets at the borders. The subsequent surrounding material layer was poured into the 
mold, enveloping the prostate phantom. The entire phantom was then allowed to cool in 
an ice water bath until solid.
Several trials o f this procedure were conducted in order to perfect seed placement, 
mixing technique, and cooling methods. In order to minimize material losses while
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testing adjustment to techniques, smaller phantoms were constructed and imaged before 
moving on to a full-scale example.
Imaging protocol development
The phantoms were imaged using the 3 Tesla Philips Intera Achieva^*^ MR system 
with a SENSE Cardiac Coil. In order to minimize artifacts that may be produced by the 
interface between the bucket and the gelatin material, the final phantom was removed 
from the container prior to scanning. The phantoms’ sizes are such that they were 
completely covered by the coil elements with the phantom center o f mass centered within 
the coil. Imaging was completed using the scan list pre-installed on the Philips Intera 
Achieva system, as well as a proton-density (PD) weighted sequence (Table 2).
Table 2. Prostate phantom imaging parameters
Scan Type
TR
(ms)
TE FOV Slice 
(ms) (mm^) Matrix NSA thickness (mm)
Number of 
Slices
Slice 
Gap (mm)
TlW_TSE_Ax 470.0 10.00 160 256 3 3 20 0.03
T2W_TSE_Ax 4768.0 90.00 160 512 3 3 24 1.00
T2W_TSE_Cor 3997.0 80.00 160 512 3 3 20 0.30
THRIVE 1mm 3.4 1.53 395 256 1 1 125 0.00
PDW TSE 2200.0 40.0 120 512 3 3 24 0.70
Emphasis was placed on the T2-weighted and PD-weighted imaging sequences as 
suggested in the literature for imaging the prostate following implant placement (DuBois 
et al. 1997 and McLaughlin et al. 2002).
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Phantom volumes were calculated using the MIPAV software application. MIPAV 
was used to manually delineate the boundary between the prostate phantom and 
surrounding tissue. These measurements were then used by the program to calculate the 
cross sectional area of each slice. The area o f each slice was then multiplied by the slice 
thickness to yield a slice volume. Summing the slice volumes gives an approximation for 
the total prostate volume that can be compared to that recorded during construction o f the 
phantom. Because the dependence o f reconstructed volume on slice thickness has been 
previously evaluated, this dependency was not re-investigated for this project (Kurmis et 
al. 2004).
Results
Images produced o f the first phantom had a mottled appearance and showed no 
distinction between the mock prostate and the surrounding materials (Fig. 10). The 
mottled appearance was attributed to air bubbles formed during the gelatin mixing 
process and was corrected on subsequent phantom trials. Review o f lab notes from the 
creation of this phantom revealed that the lack o f distinction between the two layers was 
a result o f an error in measuring the quantities o f gelatin and agar powder to be used. 
The result o f this error was that both masses within this phantom had identical 
compositions.
* Medical Image Processing, Analysis, Visualization; Center for Information Technology, National 
Institutes of Health; Bethesda, MD.
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Figure 10. T2-weighted image o f the first phantom showing air pockets introduced 
during rapid stirring (white arrows).
In order to confirm the ratios o f animal hide gelatin and agar powder were adequate 
for visual discrimination between the regions using MRI, a phantom was constructed 
with two discreet layers. One layer represented the prostate material while the other 
represented the surrounding tissue. To test the hypothesis that air bubbles introduced 
during rapid stirring of the gelatin created the speckled images, the gelatin for this 
phantom was stirred slowly until pouring. Images produced o f this phantom yielded 
much better distinction between the two layers and a smoother texture, confirming that 
the mottled appearance of the first phantom was the result o f air being introduced during 
stirring.
These images also revealed the presence o f texmred patches assumed to be ice 
crystals in both gelatin layers, and a large mass indicating the phase separation of 
different components o f the gelatin during the cooling process (Fig 11). A subsequent
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phantom that was produced with the same chemical ratios but allowed to cool in an ice 
water bath confirmed that slowing the cooling process prevented the formation o f the 
textured patches (Fig. 12). A single dummy seed was placed between the layers to
Figure 11. T2-weighted phantom image showing boundary between two gelatin 
layers (white arrow) and texture indicating the formation of ice crystals (black arrow) 
and phase separation o f mixed chemicals (gray arrows).
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Figure 12. a) T2-weighted image of a slowly cooled gelatin/agar phantom showing 
clear distinction at the boundary between the representative central gland (top) and 
peripheral zone (bottom) layers, b) Axial T2-weighted image showing the signal 
intensity variations between the peripheral zone (arrow) and central gland.
indicate the location o f the boundary in the event that a lack o f contrast between layers 
was again discovered upon imaging. Images of this phantom reveal a reasonable 
correlation between the signal intensities of the phantom and human images.
The final phantom produced images with a clear boundary between the two different 
masses and distinct signal voids indicating the locations o f the implanted seeds. A ring o f 
reduced signal intensity also presents itself. This artifact is caused by vibrations induced 
in the gelatin material by the motion o f the MRI system. Elimination o f this artifact was 
achieved by trimming off some of the surrounding material while leaving enough to show 
a contrast between the prostate phantom and its surroundings (Fig. 13).
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fFigure 13. Axial T2-weighted image o f the prostate phantom showing a ring of 
reduced signal intensity (left) and the same section after trimming away some of the 
surrounding material (right).
Without magnification, individual seeds could be visually resolved at seed spacing as 
close as 3 mm for both scan types (Fig. 14). When seeds were spaced less than 3 mm 
apart, the boundaries of the individual voids could not be resolved
Figure 14. Magnified axial T2-weighted image o f the prostate phantom showing seed 
spacing. The white arrows indicate a seed spacing of 3 mm and the black arrow 
indicates a seed spacing o f 5 mm.
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Volume measurements taken using the proton density weighted and T2-weighted 
images were 51.92 ml and 52.58 ml, respectively. This represents an underestimation of 
the 52.9 ml creation volume by 0.60% for the T2-weighted images and 2.05% for the PD- 
weighted images.
Conclusions
The combination o f agar gelatin and animal hide gelatin in appropriate ratios was 
used to create a phantom with MRI signal intensities that are visually equivalent to those 
seen in the central gland and peripheral zone o f the human prostate. The materials used 
allowed the phantom to be structurally stable enough for use without a containment 
vessel, thus avoiding the possibility o f signal attenuation or artifacts caused by a 
containment vessel. With the addition o f formaldehyde as a thermal stabilizer, the 
phantom was able to withstand several months o f imaging and transportation to and from 
the MRI suite, with outside temperatures ranging from 25° C to 43° C.
These phantoms allowed for the testing o f various MRI scan sequences to localize 
implanted brachytherapy seeds. Analysis o f the resulting images indicates that proton 
density weighted and T2-weighted MRI sequences with a 3 T field strength have the 
potential for use in differentiating the prostate from surrounding tissues while produeing 
distinet signal voids indieating the loeation o f implanted seeds.
It was not immediately evident in the phantom studies whether the extent o f the signal 
void would adversely impact the usefulness o f  MRI in post-implant dosimetric studies, 
however. In the phantom studies, no seeds were placed close enough to the capsule walls 
to be able to determine whether the signal void would interfere with the ability to
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delineate the prostate volume. It was also unclear from these results whether the size of 
the signal void would hinder the ability o f a reader to precisely determine the seed 
location relative to anatomical features and to the other seeds.
Planimetric volume estimates derived from image sets deviated from the known 
values by less than 2.5%. This is consistent with results from previous 1.5 T studies 
conducted using volumetric flasks (Tuttle 2006) as well as those comparing image-based 
estimates to pathologic specimens (Sosna et al. 2003). For reference, when compared 
with MRI, CT tends to overestimate the prostate volume by as much as 20-40% (de 
Brabandere et al. 2006).
These results suggest that post-implant dosimetric analysis is feasible using a 3 T 
MRI scanner and a cardiac coil. Tissue boundaries are clearly visible using both T2- 
weighted and proton density-weighted scans, allowing for contouring of the prostate 
volume. Using these same two scan techniques, implanted seeds are visible and may be 
resolved at spacings of 3 mm and above.
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CHAPTER 3 
PATIENT STUDIES
Introduction
In theory, higher field scanners offer the promise of a higher signal-to-noise ratio, 
higher spatial resolution, and higher spectral resolution with similar or shorter acquisition 
times over lower field strength magnets (Cunningham et al. 2005). Recent work by 
Sosna et al. (2004) and Torricelli et al. (2006) demonstrates that image quality obtained at 
3.0 T with an external phased array coil is comparable to that obtained at 1.5 T with an 
endorectal coil. Additionally, an experiment performed by Sosna et al. (2003) showed a 
close correlation between in vivo and ex vivo volume determinations performed using 3T 
MRI. However, one of the principal drawbacks to operating at higher field strength is 
the increase in susceptibility artifacts surrounding metallic implants, which may obscure 
tissue anatomy or the location o f nearby seeds (Frayne et al. 2003).
Materials and methods 
Pre-implant patients
The primary goal o f  this study is to determine whether a set o f  sean protoeols using a 
non invasive cardiac coil may be appropriately developed to allow for the localization of 
permanently implanted brachytherapy seeds while preserving anatomical detail. To that
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end, six healthy volunteers allowed for various scan protocols to be tested and evaluated 
based on these two criteria. As a starting point, it was noted that the Philips Intera system 
has a pre-installed exam card for imaging prostate anatomy and detection of prostate 
cancer. This exam card includes an axial T1 weighted turbo spin echo (TIW  TSE), axial 
and coronal T2 weighted turbo spin echoes (T2W TSE), an axial 1mm THRIVE scan, 
and a single-shot, diffusion-weighted image (SSh DWI). The parameters for each of 
these scans are listed in Table 3.
Table 3. Pre-installed prostate scan card imaging parameters
Scan Type
TR
(ms)
TE
(ms)
FOV
(mm^) Matrix
Slice 
NSA thickness
Number of 
Slices
Slice
Gap
TlW_TSE_Ax 470 10.0 160 256 3 3 20 0.03
T2W_TSE_Ax 4768 90.0 160 512 3 3 24 1.00
T2W_TSE_Cor 3997 80.0 160 512 3 3 20 0.30
SSh_DWI 2500 64.0 160 128 4 6 8 0.60
T H R IV E lm m 3.4 1.53 395 256 1 1 125 0.00
Although these scan parameters were designed for the detection of prostate cancer, it 
was noted that they may not be adequate for visualization o f implanted metallic seeds or 
for the delineation of the prostate from surrounding tissues. In order to determine which, 
if any, would be suitable for inclusion in a pre- and post-implant study, a healthy 
volunteer was imaged using the pre-installed scan parameters. Additionally, based on the 
findings o f previous research studies, a proton density weighted (PDW) sequence with a 
TR o f 2200 ms, a TE o f 40 ms, one signal average, 160 mm FOV, and a slice thickness o f
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3 mm was added (Dubois et al. 1997). Each of the images was then visually evaluated on 
their suitability for a pre- and post-implant volume estimates and based on overall image 
clarity and distinctness of prostate anatomy.
Following the elimination of inappropriate scan sequences, the remaining sequences 
were varied to determine which would yield the clearest anatomical boundaries, as well 
as minimize the total scan time. Adjustments were made to the number of signal 
averages (NSA) acquired as shown in Table 4. All other parameters were held constant 
to determine what effect the increase in the number o f signal averages would have on the 
image quality.
Table 4. Variation in scan time with increasing number of signal averages
Scan Type
Slice
NSA thickness (mm)
Number of 
Slices
Slice 
Gap (mm)
Scan
Time
P D W T S E A x 2 1.00 24 4.00 05:21.2
P D W T S E A x 4 1.00 24 4.00 10:42.4
PDW_TSE_Ax 6 1.00 24 4.00 16:03.6
PDW TSE Ax 8 1.00 24 4.00 21:24.8
Post-implant patients
With one exception, each of the five patients was selected for this study based on a 
history o f prostate cancer treated with permanent implant brachytherapy. The exception 
to this inclusion was the first patient imaged, who had undergone external beam radiation 
therapy o f the prostate, but had three fiducial markers implanted before treatment. This
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patient was included to evaluate the ability to visualize individual implanted seeds 
without interference from field disturbances resulting from other nearby seeds.
General protocols for imaging this group o f patients were similar to that used for 
imaging the healthy volunteer group, with patients undergoing proton density-weighted 
scans. In the case of the post-treatment patients, emphasis was plaeed on adjusting 
parameters to maximize the visualization of the seeds. Sliee thickness was varied 
between patients to determine which slice thickness would allow for clear anatomical 
boundaries while producing distinct signal voids indicating seed locations. Table 5 
details the parameters varied.
Table 5. Post-implant prostate patient imaging parameter variations used
Scan Type
TR
(ms)
TE
(ms)
FOV
(mm^) Matrix NSA
Slice
thickness
Slice
Gap
Number of 
Slices
PDW TSE Ax 2200 40 160 256 4 4.0 1.0 16
P D W T S E A x 2200 40 160 256 4 3.0 0.4 20
P D W T S E A x 2200 40 160 256 4 2.0 0.4 24
PDW TSE Ax 2200 40 160 256 4 1.0 0.4 40
P D W T S E A x 2200 40 160 256 4 1.0 2.0 14
PDW TSE Ax 2200 40 160 256 4 1.0 4.0 14
Images were evaluated for general clarity and anatomical detail, as in the case of 
those images acquired during the healthy volunteer portion o f the study. Additionally, 
the images were examined to determine whether or not the seeds were visible and 
whether or not the prostate margins were obscured by the seeds.
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Variations in slice thickness between the two modalities made direct comparison 
between CT and many o f the MRI data sets impractical. For the data set with a 1 mm 
slice thickness with no gap, as well as the 1mm slice thickness with a 4 mm gap, the data 
images were compared to sets o f CT images that had previously been dosimetrically 
evaluated by a trained physicist using the Variseed 7.1^ treatment planning system. 
Seeds were noted whenever they were visualized on one modality but not the other.
For seed localization and counting, two observers examined each set o f images 
multiple times in a randomized order with no prior knowledge o f the number o f seeds 
placed. Along with printed data sets, both observers were given information on slice 
thickness and slice gap. Where applicable, seed locations were compared on successive 
slices in order to systematically omit those signal voids that indicate a single seed present 
in multiple slices. Observers were asked to keep a tally o f the number o f seeds counted. 
The number of seeds counted was then compared to the number implanted, as recorded in 
the patients’ procedural notes.
Results
Pre-implant studies
It was immediately recognized that some o f the resultant images would not be 
adequate for inclusion in this study based on the lack o f anatomical detail. For instance, 
while useful for a pathological evaluation o f the prostate tissue, the diffusion-weighted 
im age sh ow s little  anatom ical detail (F ig . 15). S im ilarly , the T 1-w eigh ted  im ages, 
while having a faster acquisition time than T2-weighted images, show little tissue 
contrast between the prostate itself and surrounding musculature (Fig. 16). Because the
* Varian Medical Systems, Palo Alto, California, USA.
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Figure 15. Diffusion-weighted image in the axial plane o f a healthy male prostate.
Figure 16. T1-weighted image of the male pelvis in the axial plane showing the lack 
o f contrast between the prostate (white arrow) and levitator ani muscles (black 
arrows).
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THRIVE 1 mm sequence is designed for use with contrast enhancement: these images 
without contrast injection do not exhibit the degree o f soft-tissue contrast for the areas 
being considered that would allow for easy delineation o f the prostate tissue (Fig. 17). 
Evaluation o f the THRIVE scan revealed little signal contrast between the anterior rectal 
wall, the prostate, and the levitator ani muscles.
Figure 17. THRIVE 1 mm scan o f the male pelvis in the axial plane. Note the lack 
o f contrast between the prostate (white arrow) and surrounding tissues (gray arrows).
Shown in Fig. 18, it was immediately apparent that the T2-weighted images yielded 
excellent soft tissue contrast and anatomical detail in both the axial and coronal planes. 
Using these scan parameters, the boundaries between the prostate and surrounding tissues
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were readily discernable, as was the prostatic urethra. No changes were made to the T2- 
weighted scan parameters based on these results.
Figure 18. T2-weighted images of a healthy male prostate in the axial (left) and 
coronal (right) planes. In both images, the prostate itself is indicated by the white 
arrow and the levitator ani muscles are indicated by the gray arrows.
The images from the proton-density weighted scans appeared grainy in comparison to 
the T2-weighted scans, suggesting a lower signal to noise ratio (SNR). In order to be 
useful in this study, the overall image quality needed to be improved to accurately 
delineate the prostate volume. This was achieved by increasing the number of signal 
averages (NSA) from two to four, six, and eight averages (Fig 19). Although increasing 
the number of averages increases the signal to noise ratio by measuring and summing the 
signal received for a given slice multiple times, there is a tradeoff in time of acquisition. 
Total measurement time is directly proportional to the NSA such that, when increasing 
from two to eight averages, there is an increase in the total scan time from 215 to 730 s.
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Figure 19. Axial proton density weighted images of a healthy male pelvis showing 
the increase in overall image clarity achieved by increasing the NSA from (a) 2 to (b) 
4, (c) 6 and (d) 8.
Post-implant studies
Figure 20 illustrates how image quality varies as a function o f slice thickness for PD- 
weighted scans. The 1 mm slice thickness images showed distinct signal voids and clear
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anatomical boundaries. In comparison, the signal voids in the images acquired with a 3 mm 
slice thickness appear broadened (Fig. 20). This effect is even more pronounced in the
Figure 20. Axial proton density weighted images o f the male pelvis following 
implantation. Images were acquired using (a) 1 mm, (b) 2 mm, (c) 3 mm, and (d) 4 
mm slice thicknesses.
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images acquired with a 4 mm slice thickness. Additionally, images acquired using a 4 
mm slice thickness reveal superimposed signal voids from the inclusion o f more than 
one seed on different planes in the same slice selection (Fig. 21).
Figure 21. Axial proton density weighted image of a male pelvis acquired using a 4 
mm slice thickness. Dual signal artifacts are indicated by white and black arrows.
On images with a small slice thickness, seeds were readily visualized within the gland 
itself, along the glandular borders, and outside of the prostate capsule (Fig. 22). Close 
seed grouping was not found to be a factor in the number of seeds counted within these 
data sets. In general, the number o f seeds implanted (maximum 90) allowed for a seed 
distribution that was spaced such that individual seeds could be readily distinguished 
from their neighbors. In the instances where two or more seeds were placed sufficiently 
close to cause the two voids to merge, the size o f the void was significantly larger than
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neighboring voids. A similar effect was noted in the corresponding CT images, with an 
enlarged area o f signal hyperintensity indicating the presence o f multiple seeds.
One instance was noted in which a seed was visualized on a CT image without being 
counted on the corresponding MR image. This patient consented to a second MRI
Figure 22. Axial proton density weighted images of a male pelvis showing seed 
locations within the gland (white arrow), along the prostate capsule (black arrow), 
and outside of the gland (gray arrow).
session in which the absence of a seed in that plane was confirmed. An assumption was 
made based on the previous experience of the physicist that performed the dosimetric 
evaluations that the seed had likely migrated to the urethra and had been subsequently 
expelled in the urine. Because the CT scan was not repeated, however, no conclusions 
could be drawn as to the source of this anomaly.
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When the image sets were evaluated with no prior knowledge o f the number o f seeds 
implanted, an overall average o f 70 out o f 86 seeds were visualized across all slice 
thicknesses. The 1 mm slice thickness with a 4 mm gap had the highest number o f seeds 
visualized at 84 out o f 90, while the 4 mm slice thickness with a 1 mm gap had the lowest 
visualization rate with 60 out o f 78. Table 6 lists the percentage number o f seeds 
visualized for each data set.
Table 6. Percentage o f seeds visualized as a function o f varying slice thickness
Data Set Slice 
Thickness (mm)
Slice 
Gap (mm)
Average Percentage 
o f Seeds Visualized
1 4.0 1.0 68.8±16.8
2 3.0 0.4 76.4±13.1
3 2.0 0.4 81.3±12.4
4 1.0 0.4 85.2±17.2
5 1.0 2.0 91.7±1.6
6 1.0 4.0 93.3±2.2
Conclusions 
Pre-implant studies
Three o f the five image sequences pre-installed on the Philips Intera system were 
found to be unsuitable for inclusion in this study. For the T1-weighted and 
THRJVE Imm scans, the lack of anatomic detail and soft-tissue contrast make 
delineation o f the glandular borders difficult and prone to the same subjective judgment
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necessary for CT-based glandular delineation (Al-Quaisieh et al. 2001). In the case o f the 
THRIVE 1mm scan, this lack o f inherent contrast was expected since this scan is 
typically used in contrast studies following the intravenous administration gadolinium.
From the images reviewed, the T2-weighted scans provided the best soft tissue 
contrast and anatomical detail in both the axial and coronal planes. Accordingly, this 
scan was included in the final protocol as an anatomy baseline for comparison to the 
other scans selected. Although not as clear as the T2-weighted scans, the PDW scan also 
yielded clear glandular borders and was included in the parameters evaluated for their 
usefulness in determining seed locations following the implant procedure.
Post-implant studies
Data suggests a direct correlation between image slice thickness and the percentage of 
seeds counted. A 4 mm slice thickness yielded the worst visualization rate with 68.8% of 
seeds visualized, while a 1 mm slice thickness yielding the highest percentage o f seeds 
visualized with between 85.2% and 93.3%, depending on the spacing between slices. 
These findings are consistent with previous studies that evaluated the effect o f slice 
thickness on seed localization using both CT and MRI (De Brabandere et al. 2006, Prete 
et al. 1998). A large slice thickness increases the chance that more than one seed may 
intersect the scan plane and contribute to the loss o f signal at that position. For an 
observer, it may not be possible to tell whether the signal void is produced by a single 
seed or multiple seeds. This effect is also seen in post-implant CT images when a seed 
appears on contiguous slices.
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Reduction o f  the slice thickness to 1 mm improves seed definition, while allowing for 
precise determination o f prostate boundaries. However, the tradeoff to the slice thickness 
adjustment is a decrease in the signal to noise ratio, resulting in images with a grainy 
appearance. To compensate for the decreased signal to noise ratio while maintaining a 
constant FOV, each slice must be acquired multiple times with the resulting data 
summed, which results in increased scanning times. Increased scan times may lead to 
greater patient discomfort and motion, which can degrade image quality. Using four 
signal averages appears to be a suitable compromise, yielding clear images while 
maintaining a scan time o f just less than eleven minutes in order to minimize patient 
discomfort.
As an alternative solution to the decreased SNR from thinner slice thicknesses, the 
gap between slices may be increased, which results in a reduction in the total number of 
slices needed to cover the entire prostate volume. Broadening the slice gap has the added 
advantage of simplifying the seed localization and counting process by reducing the 
number o f images through which signal voids must be tracked.
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CHAPTER 4 
SUMMARY AND CONCLUSIONS
Summary
Magnetic Resonance Imaging (MRI) yields images with soft tissue contrast that is 
superior to CT or ultrasound, but has been under-appreciated as a dosimetric tool in LDR 
brachytherapy due to a perceived difficulty in localizing the implanted seeds. Compared 
to 1.5 T MRI with a whole body coil, the use of a SENSE compatible cardiac coil 
coupled to a 3 T MR spectrometer yields a higher signal to noise ratio and increased 
spatial resolution. Work by Sosna et al. (2004) and Torricelli et al. (2006) demonstrates 
that image quality obtained at 3.0 Tesla (T) with an external phased array coil is 
comparable to those obtained at 1.5 T with an endorectal coil without the associated 
gland deformation or peristaltic motion artifacts. However, one o f the principal 
drawbacks to operating at a higher field strength is the increase in susceptibility artifacts 
surrounding metallic implants, which may obscure anatomical information or the location 
of other implants (Frayne et al. 2003).
The aim of this work was to determine whether images acquired from a variety of 
pulse sequences using a cardiac coil coupled with 3T MRI are adequate for pre-implant 
treatment planning and post-implant dosimetric analysis o f permanently implanted 
brachytherapy seeds. Adequacy was determined by the degree to which anatomic detail
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allows for precise delineation o f prostate boundaries, as well as the ability to accurately 
localize the implanted seeds at least as well as with CT.
To that end, a series o f phantoms were created using a combination o f animal hide 
gelatin and agar gelatin that allowed for the testing o f various MRI scan sequences to 
localize implanted brachytherapy seeds. Analysis of the resulting images indicates that 
proton density weighted and T2-weighted MRI sequences on a 3 T spectrometer have the 
potential to differentiate the prostate from surrounding tissues while producing distinct 
signal voids at implanted seed locations.
Although some have argued that variations in prostate volume determination from CT 
images have little impact on dosimetric quality factors, it is important to note that this 
assertion is only valid when a periprostatic margin is included as part o f the target 
volume (Bice et al. 1998, Merrick et al. 1999). As has been noted previously, the 
inability to distinguish the prostate glandular boundary from the surrounding tissues is the 
strongest factor in volume determination uncertainty (Al-Quaisieh et al. 2001). An 
assessment o f the impact o f imaging uncertainties on dosimetric evaluation o f prostate 
brachytherapy implants concluded that volume calculation uncertainties had a larger 
impact on tumor control probability than either seed detection rates or seed localization 
uncertainties (Lindsay et al. 2003).
Volumes calculated from image sets were less than 2.5% smaller than those measured 
during phantom creation. Volume estimates may be further improved through a 
reduction in slice thickness (Kurmis et al. 2003), but at the expense of increased scan 
times, which may increase patient discomfort, movement, and subsequent image 
degradation.
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The inclusion of the proton density weighted sequences with a short TE allowed for 
more precise determination o f seed locations by minimizing the signal void surrounding 
the seeds and decreasing the incidence o f signal void overlap that can obscure both 
anatomy and seed position. Using this sequence, seeds were resolved at spacings as low 
as 3 mm.
Seed detection rate was found to be dependent on slice thickness used for the image 
acquisition. In general, smaller slice thicknesses had higher detection rates with the 
4 mm slice thickness yielding the worst visualization rate with 68.8% of seeds visualized, 
and the 1 mm slice thickness yielding the highest percentage of seeds visualized with 
between 85.2% and 93.3%, depending on the spacing between slices. These findings are 
consistent with previous studies that evaluated the effect of slice thickness on seed 
localization using both CT and MRI (De Brabandere et al. 2006, Prete et al. 1998).
Although the detection rates for this study were below the 95% suggested by Yi Su et 
al. (2005) for accurate estimation o f dose quality parameters, the maximum detection rate 
o f 93.3% is above those reported for T2-weighted MRI studies (Bloch et al. 2007.) 
Additionally, research conducted by Dubois et al. (1997) suggests that there is a learning 
curve associated with the detection o f implanted sources on MR images. Dubois further 
suggests that this curve may be mastered in as few as five cases by initially using CT 
images along side the MR images as a learning guide.
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CONCLUSIONS
The results o f this study suggest that images acquired using a 3 T magnetic resonance 
spectrometer coupled to a cardiac coil may be used to reliably identify permanently 
implanted brachytherapy seeds in the prostate without the use o f an endorectal coil. The 
optimized protocols may be seen in Table 7. Tissue boundaries are clearly visible using 
both T2-weighted and proton density-weighted scans, allowing for contouring o f the 
prostate volume. Additionally, the short TE of the proton density-weighted scans 
minimizes the susceptibility artifact surrounding the seeds to allow the seeds to be clearly 
visualized while preserving anatomical boundary information. Slice thickness may be 
reduced to maximize both volume estimates and seed detection rates, while interslice 
spacing may be increased to shorten image acquisition times and simplify the seed 
counting process.
Table 7. Final post-implant prostate imaging protocols
Scan Type
TR
(ms)
TE
(ms)
FOV
(mm^) Matrix NSA
Slice
thickness
Slice
gap
T2W TSE Ax 4800 90 160 512 3 3 1.0
T2W_TSE Cor 4800 90 160 512 3 3 0.3
T2W_TSE_Sag 4800 90 160 512 3 3 0.3
PDW TSE Ax 2200 40 160 256 4 1.0 4.0
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March 6,2007
Jason Davis
UNLV Department o f Health Physics 
6854 Baby Jade Ct.
Las Vegas, Nevada 89148
Via Fax:
Dear Mr. Davis.
The American Association o f Physicists in Medicine hereby grants permission for Mr. Jason 
Davis to use the material outlined below in the final draft o f his Master’s Thesis:
Smith S, Wallner K, Merrick G, Butler W, Grimm P. “Interpretation of pre-versus 
postimplant TRUS images’’. Medical Physics 30,2003; 920-924.
Figure 1 (page 921)
Han BH, Wallner K, Merrick G, Butler W, Sutlief S, Sylvester J. “Prostate brachytherapy 
seed identification on post-implant TRUS images’’. Medical Physics 30,2003; 898-900.
Figure 1 (page 899)
Alterovitz R, Goldberg K, Pouliot J, Hsu IJ, Kim Y, Norworolski SM, Kurhanewicz J. 
“Registration of MR prostate images with biomechanical modeling and nonlinear 
parameter estimation”. Medical Physics 33,2006; 446-454.
Figure 2 (page 447)
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UNLV
JN IV C R S ITY  o r  NEVADA LAS V C C A 5
INFORMED CONSENT 
Department o f Health Phvsics
TITLE OF STUDY: Investigation o f Magnetic Resonance Imaging as a tool for Brachjtherapy  
Permanent Seed Implantation Treatment of Prostate Cancer 
IX \T;s TIGATQR(S): Jason D ans. PhilUn Patton
C ONT ACT PHONE NUMBER: 7Q2 -89 5 -3 5 fA fPhlllln Pattoni. 702-328-2368 (Jason Daslsl
Pum ose of the Study
You are invited to pailicipate in a research study. The purpose o f  this study is to investigate the use ol 
Magnetic Resonance Imaging (MRI) as a method o f imaging the prostate that will allow physicians to 
accurately plan a pennanent implant cancer treatment and evaluate the success o f these treatments.
Paiticipants
You are being asked to paiticipate in the study because you liave been diagnosed witli prostate cancer, 
are considered a candidate for implantation therapy, and have no known medical conditions such as 
claustrophobia, metal implants, etc. that would prevent you from being imaged by MRI.
Procedures
If  you volunteer to participate in tliis study, you will be asked to do tlie following: lie on your back in 
an MRI tube for approximately 45 minutes while the scan is completed. After your treatment, you w il 
be asked to repeat the scan.
Benefits of Participation
There mnv not be direct benefits to you as a participant in this study. However, we hope to learn how 
MRI may be used to plan prostate cancer treatments and evaluate the success o f  tliese treatments.
Risks of Participation
Tliere are risks involved in all research studies. TIris study may include orrly minimal risks. Because 
the process requires that you remain completely s till you may become uncomfortable during the 
scanning process. Additionally, you may experience sorrre claustrophobia while in the MRI tube.
Cost /Compensation
Tliere will not be financial cost to you to participate in this study. The study will take approximately 
90 minutes o f your time, or 45 minutes each on two separate days. Yoir will not be compensated for 
yoiu time. The Universit}’ ofN e\’ada. Las Vegas may not provide compensation or free  rrtedical care 
fo r  an unanticipated irrjury sustained as a result o f  participating in this r esearch strrdy.
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UNLV
I N IV C R S IT Y  o r  NEVADA L.AS V E G A S
INFORMED CONSENT 
Depaitineot of Health Phvsics
TITLE OF STUDY: Investigation of Magnetic Resonance Imaging as a tool for Brachytherapy 
Permanent Seed Implantation Treatment of Prostate Cancer 
IN\XSTIGATOR(S): Jason Davis. Phillip Patton
CONTACT PHONE NUMBER: 702-89S-3S5S tPhillip Pattonl. 702-328-2368 (Jason Daslsl 
Contact Information
If  you have any questions or concerns about the study, you may contact Jason Davis at (702)328-2368 
or Phillip Patton, PhD at 702-895-3555. For questions regarding the rights o f  research subjects, any 
complaints or comments regarding the maimer in which the study is being conducted you may contact 
the UNLV Office for the Protection of Research Subjects at 702-895-2794.
\  oluntaiw Participation
Your participation in tliis study is voluntary. You may refiise to participate in this study or in any part 
of this study. You may withdraw at any time w ithout prejudice to your relations with the imiversity. 
You are encouraged to ask questions about tliis study at tire begimiing or any time during tlie research 
study.
Confidentiality
All infortnation gathered in this study will be kept conqiletely confidential. No reference will be made 
in written or oral materials that could link you to tliis study. All records will be stored in a locked 
facility at UNLV for at least 3 years after completion o f the study. After the storage time the 
information gathered will be slnedded.
Participant Consent:
I have read the above information and agree to paiticipate in this study. I am at least 18 years o f age 
with no medical conditions such as claustrophobia, metal implants, or implanted cardiac pacemaker 
tliat prevent me from being imaged using a magnetic resonance imaging spectrometer. A copy o f tliis 
form has been given to me.
Signature of Participant Date
Participant N am e (Please Print)
Participant Note: Please do not sign this document i f  the Approval Stamp is missing or is expired.
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APPENDIX III
MRI IMAGE ACQUISITION METHODS
6 8
PROSTATE MRI SCAN ACQUISITION NOTES
Pre-Scan Setup
1. Select ‘Patient’ on the menu bar.
2. Select ‘New Exam.’
3. Enter the following information:
a. Patient’s coded name.
b. Registration number.
e. Patient’s date o f birth (MM/DD/YYYY).
d. Patient gender as male.
e. Patient’s weight (in kg).
f. Any additional comments.
g. The other fields can be left blank.
4. Clink ‘Enter.’
5. Click ‘Proceed.’ The system will not automatically switch to scan mode.
Patient Positioning
1. Instruct patients to remove all metallic objects that may be on their person, 
including watches and jewelry.
2. If the patient has a metallic zipper or metal rivets in their clothes, allow them to 
change into a set of scrubs or a hospital gown.
3. Lower the couch to the parking position using the Out/Down tumble switch 
located on the control panel. So the patient should be able to comfortably easily 
sit and then lay on the eoueh, stopping the eoueh somewhat above the parking 
position may be necessary.
4. Place the cardiac coil on the eoueh. Do not plug the coil into the scanner at this 
time. Add other mattresses, knee cushions, and pillows as needed for patient 
comfort. Be sure the patient is as comfortable as possible to minimize motion 
artifacts. Blankets, sheets, or parkas may be used as the room may become cool
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during the procedure. Each patient should also be provided with a set o f ear plugs 
to minimize discomfort due to machine noise.
5. Instruct the patient to lie on their back with feet pointed in toward the bore. Align 
the patient’s pelvic crest with the top o f the cardiac coil. The patient may lie with 
their arms above their head or folded across their chest, so long as the position is
comfortable enough to minimize motion. Raise the couch using the Up/In tumble 
switch.
6. Press the Tight visor’ button on the control panel. This will activate the laser 
registration grid lines. Using the laser beams, place the patient so the 
approximate location o f the prostate lies in the middle of the illuminated cross. 
The coil may now be plugged into the scanner. Press ' Travel-to-scanplane ’ 
button on the control panel. The laser beams will turn off automatically. Use the 
Up/In tumble switch to place the patient into the tube. The couch will stop 
moving once the isoeenter has been reached.
7. Once all the scans have finished, remove the patient from the tube. Use the 
Out/Down tumble switch on the control panel until the couch is in the parking 
position, or to a position where the patient is able to step down safely.
8. Be sure to tightly close the exam room door before starting any scans.
Imaging Scan
1. Select the ‘Hospital’ folder in the Exam Cards under Toolbar.
2. Select the folder ‘User Defined.’
3. Scroll down and select the ‘UNLV’ folder.
4. Select the first scan list ‘UNLV Prostate.’
5. Copy the scans and paste them in the Exam Cards.
6. In the Exam Cards, click on the Survey scan to open up the scan. Make sure the
geometry (GEO) field is blank or the survey scan w ill not run. Click ‘Proceed,’
then ‘Start Scan’ to start the Survey.
7. When the Survey has finished, click on the Exam Cards for the R ef SCC SENSE 
to open up the scan. Make sure the coil selected is the cardiac coil. Respiratory 
compensation should be set to ‘Breath Hold.’ Click ‘Proceed’ to start the
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Ref SCC SENSE scan. Following the on-screen prompts, tell the patient when 
to hold their breath and when to begin breathing again.
8. When the reference scan has finished, select the appropriate reference scan image 
to begin planning the other scans. Double click the next scan in the current exam 
card window to open that scan for planning. A colored box should appear in the 
reference scan image. Align this box so that the entire region o f interest is 
covered. For coronal reference views, the center circle within the plaiming 
volume should line up just below the bladder trigone and the top o f the box 
should line up approximately with the center o f the femur head. For sagittal 
reference scans, the lower edge of the scan volume box should line up with the 
fold o f the leg (between the bottom of the leg and the top o f the buttock). On 
axial scans, the prostate should be visible above the darkly colored rectum and 
between the two femurs.
9. Under the ‘Initial’ tab, use the Survey scan as a guide and adjust the field o f view 
(FOV) to the desired size. Ensure that foldover suppression is set to ‘Yes,” then 
click ‘Proceed,’ then ‘Start Scan’ to begin scanning.
10. While the first scan is running, steps 8 and 9 can be repeated for the remaining 
scans. If the first scan has not finished and the plaiming has been completed for 
each o f the subsequent scans, clicking ‘Proceed’ for the subsequent scans will 
allow the scans to proceed without interruption once the previous scan has 
finished.
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